Dr. Reddy's Laboratories Ltd. Sponsored ADR Forecast, price target & analysts
Dr. Reddy's Laboratories Ltd. Sponsored ADR Target price 2024 - Analyst rating & recommendation
Dr. Reddy's Laboratories Ltd. Sponsored ADR Classifications & Recommendation:
Dr. Reddy's Laboratories Ltd. Sponsored ADR Price Target
| Target Price | $79.51 |
| Price | $79.20 |
| Potential |
0.39%
register free of charge
|
| Number of Estimates | 35 |
|
35 Analysts have issued a price target Dr. Reddy's Laboratories Ltd. Sponsored ADR 2025 .
The average Dr. Reddy's Laboratories Ltd. Sponsored ADR target price is $79.51.
This is
0.39%
register free of charge
$95.65
20.78%
register free of charge
$56.19
29.06%
register free of charge
|
|
| A rating was issued by 36 analysts: 11 Analysts recommend Dr. Reddy's Laboratories Ltd. Sponsored ADR to buy, 10 to hold and 15 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock has an average upside potential 2025 of
0.39%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.37 | 3.70 |
| 10.21% | 9.86% | |
| EBITDA Margin | 28.20% | 27.73% |
| 6.90% | 1.65% | |
| Net Margin | 19.96% | 18.62% |
| 8.45% | 6.69% |
34 Analysts have issued a sales forecast Dr. Reddy's Laboratories Ltd. Sponsored ADR 2025 . The average Dr. Reddy's Laboratories Ltd. Sponsored ADR sales estimate is
This results in the following potential growth metrics:
32 Analysts have issued an Dr. Reddy's Laboratories Ltd. Sponsored ADR EBITDA forecast 2025. The average Dr. Reddy's Laboratories Ltd. Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Dr. Reddy's Laboratories Ltd. Sponsored ADR Analysts have issued a net profit forecast 2025. The average Dr. Reddy's Laboratories Ltd. Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.04 | 4.14 |
| 19.53% | 2.48% | |
| P/E | 19.12 | |
| EV/Sales | 3.35 |
20 Analysts have issued a Dr. Reddy's Laboratories Ltd. Sponsored ADR forecast for earnings per share. The average Dr. Reddy's Laboratories Ltd. Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Dr. Reddy's Laboratories Ltd. Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Dr. Reddy's Laboratories Ltd. Sponsored ADR...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
